Dr. Veldkamp's long-term interests are HIV care, general infectious diseases and travel/tropical medicine. These diseases especially affect underserved populations in low resource settings. The challenge to diagnose and treat these conditions with minimal cost and maximal efficacy appeals to him. Dr. Veldkamp strives to enhance the health care providers' impact in patient-centered care settings.
Dr. Veldkamp's long-term clinical interests are HIV care, general infectious diseases and Travel/Tropical medicine. These diseases especially affect underserved populations and low resource settings. The challenge to diagnose and treat these conditions with minimal cost and maximal efficacy appeals to him. Through motivational interview techniques Dr. Velkamp tries to enhance the health care providers' impact in patient-centered care settings.
Dr. Veldkamp's overall goal is to improve equal access to good quality healthcare worldwide. He wants to achieve this goal by educating health care workers on how to provide non-judgmental and excellent medical care, especially in the field of infectious diseases. By motivating and teaching primary care providers across the globe, he hopes to impact positively on the treatment cascades by promoting screening, linking to care, retention in care, treatment and virologic control (HIV) or cure (HCV), and restricted but rational use of antimicrobials.
- BS, Goois Lyceum, Bussum, Netherlands, 1981
- MD, Rijks Universiteit Groningen, 1986
- MS, Physiology and Biophysics, University of Alabama at Birmingham, 1988
- MD, University of Alabama at Birmingham, 1992
Education & Training
Gomez C. A., Vela-Duarte D., Veldkamp P. J. Infectious Pneumorrhachis Because of Emphysematous Pyelonephritis. Journal of the American Medical Association Neurology. 2017; 74(11): 1374-1375.
Simha A., Webb C. M., Prasad R., Kolb N. R., Veldkamp P. J. Moral Distress with Obstacles to Hepatitis C Treatment: A Council of Academic Family Medicine Educational Research Alliance. Journal of the American Board of Family Medicine. 2018; 31(2): 286-291.
Veldkamp P. J., Mellors J. W., Halvas E. K. Should we be testing for baseline integrase resistance in patients newly diagnosed with human immunodeficiency virus?. Clinical Infectious Diseases. 2018; 66(11): 1820-1821.
Mehta K., IM A., Rahman F., Wang H., Veldkamp P. Epidemiology and Outcomes of Hematopoietic Stem Cell Transplantation in Human Immunodeficiency Virus-Positive Patients From 1998 to 2012. Clinical Infectious Diseases. 2018; 67(1): 128-133.
Simha A., Maria Webb C., Prasad R., Kolb N. R., Veldkamp P. J. Moral Distress with Obstacles to Hepatitis C Treatment: A Council of Academic Family Medicine Educational Research Alliance (CERA) Study of Family Medicine Program Directors. Journal of the American Board of Family Medicine. 2018; 31(2): 286-291.
Fleshner M. J., Kennedy A. J., Veldkamp P. J., Childers J. W. Would You Be Surprised If This Patient Died This Year? Advance Care Planning in Substance Use Disorder. Journal of General Internal Medicine. 2019; 34(11): 2630–2633.
Rao M., Dadey, L., Glowa T., Veldkamp P. Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use. Infectious Diseases. 2021; 448–453: 13.
Koretz Z. A., Apostolopoulou A., Chen E., Veldkamp P., Viehman J. A., Sahel J. A., Chhablani J., Dansingani K. K., Errera M. H., Bonhomme G. R. Clinical Features and Multimodal Imaging in Atypical Posterior Uveitis Secondary to Bartonella Henselae Infection. Ocular Immunology and Inflammation. 2021; 1-8.
- Academy of Master Educators (AME), 2009-2016
- Clinical Educator of the Year Award, 2010
- Excellence in Education Award as Course Director by Class of 2012 (UPSOM), 2010
- Kennth E. Schuit Teaching Award (UPSOM), 2011
- Alpha Omega Alpha Faculty Award, Gamma PA Chapter, 2015
- Recipient, Excellence in Education Award, Infectious Diseases Fellowship Program, 2016
